Search

everythinglearnresearchcommunity

for

Search:↓

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Sorafenib can cause a unique skin reaction.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Certain drugs that block specific enzymes can help treat prostate diseases.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Blocking IL-8 can reduce skin rashes from cancer treatment.